Fractyl Health (GUTS) Current Assets (2023 - 2026)
Fractyl Health (GUTS) reported Current Assets of $65.9 million for Q1 2026, up 40.12% year-on-year from $47.0 million in Q1 2025, and down 24.73% quarter-over-quarter from $87.6 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Current Assets data on file, last reported at $65.9 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 40.12% year-over-year to $65.9 million; the trailing twelve-month figure through Mar 2026 stood at $65.9 million (up 40.12% YoY), and the FY2025 full-year result was $87.6 million, up 22.04% from the prior year.
- Current Assets for Q1 2026 stood at $65.9 million, down from $87.6 million in the prior quarter.
- Across five years, Current Assets topped out at $124.5 million in Q1 2024 and bottomed at $26.7 million in Q2 2025.
- A 4-year average of $73.3 million and a median of $75.7 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets surged 101.31% in 2024 and sank 74.95% in 2025, its largest moves.
- Tracing GUTS's Current Assets over 4 years: stood at $35.6 million in 2023, then jumped by 101.31% to $71.8 million in 2024, then rose by 22.04% to $87.6 million in 2025, then fell by 24.73% to $65.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $65.9 million, $87.6 million, and $79.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 18.21 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 65.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.92 Mn |
| Dec 31, 2025 | 87.58 Mn |
| Sep 30, 2025 | 79.70 Mn |
| Jun 30, 2025 | 26.69 Mn |
| Mar 31, 2025 | 47.05 Mn |
| Dec 31, 2024 | 71.76 Mn |
| Sep 30, 2024 | 87.65 Mn |
| Jun 30, 2024 | 106.56 Mn |
| Mar 31, 2024 | 124.47 Mn |
| Dec 31, 2023 | 35.65 Mn |